Cell Line News and Research

RSS
Innovative experimental therapy may stop growth of triple-negative breast cancer

Innovative experimental therapy may stop growth of triple-negative breast cancer

New approach to broadly acting, highly effective HIV vaccine

New approach to broadly acting, highly effective HIV vaccine

Newly developed cell models can open up new avenues for ocular drug discovery

Newly developed cell models can open up new avenues for ocular drug discovery

SDSU researchers show cancer-inhibiting potential of flavonoid metabolite

SDSU researchers show cancer-inhibiting potential of flavonoid metabolite

Gene discovery in fruit flies could provide clues to counteract mitochondrial diseases

Gene discovery in fruit flies could provide clues to counteract mitochondrial diseases

New method for correcting hypoxic conditions of the central nervous system

New method for correcting hypoxic conditions of the central nervous system

Researchers assess safety of conditionally immortalized cells for bioartificial kidney application

Researchers assess safety of conditionally immortalized cells for bioartificial kidney application

Researchers discover molecular underpinnings of Alexander disease

Researchers discover molecular underpinnings of Alexander disease

Subpopulations of tumor cells may exhibit diverging behaviors from bulk tumor

Subpopulations of tumor cells may exhibit diverging behaviors from bulk tumor

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

New technique uses light to control lifetime of protein inside the cell

New technique uses light to control lifetime of protein inside the cell

Novel, cost-effective method successfully identifies aggressive tumors

Novel, cost-effective method successfully identifies aggressive tumors

Novel antibodies could provide a universal flu vaccine

Novel antibodies could provide a universal flu vaccine

CELLINK’s I-DOT can facilitate genetic cancer diagnostic research, study shows

CELLINK’s I-DOT can facilitate genetic cancer diagnostic research, study shows

University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy

University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy

Researchers develop new cheap method to identify aggressive tumors

Researchers develop new cheap method to identify aggressive tumors

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

BioStreamline: Streamlining the development of next generation biotherapeutics

BioStreamline: Streamlining the development of next generation biotherapeutics

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.